Andrew Booth

ABCL

Andrew Booth serves as Chief Financial Officer at AbCellera Biologics Inc. (ABCL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$1.58M

Total Sells

1 trades

$30.60M

Net Position

Net Seller

$29.02M

Companies Traded

ABCL

Active Period

Jun 2021 – May 2023

4 total trades

Most Recent

Buy ABCL

May 26, 2023 · $99.3K

Andrew Booth's Insider Trading at AbCellera Biologics Inc. (ABCL)

Buys

3 · $1.58M

Sells

1 · $30.60M

Total Shares Bought

167,000

Total Shares Sold

1,200,000

ABCL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
May 26, 2023	Buy	14,500	$6.85	$99.3K
May 12, 2022	Buy	85,000	$5.79	$492.1K
Nov 11, 2021	Buy	67,500	$14.71	$993.1K
Jun 9, 2021	Sell	1,200,000	$25.50	$30.60M

Related Insiders

John S. Montalbano

Director

ABCLBuy · Nov 26, 2025

Explore More Insider Trading Data

ABCL Insider Trading Activity

View all insider trades at AbCellera Biologics Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity